Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Diabetic Macular Edema Global Clinical Trials Review, H2, 2017: By Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type & End Point Status - Research and Markets

Research and Markets
Posted on: 31 Aug 17

The "Diabetic Macular Edema Global Clinical Trials Review, H2, 2017" clinical trials has been added to Research and Markets' offering.

The clinical trial report, Diabetic Macular Edema Global Clinical Trials Review, H2, 2017" provides an overview of Diabetic Macular Edema clinical trials scenario. This report provides top line data relating to the clinical trials on Diabetic Macular Edema. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using the author's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope of the Report:

  • The report provides a snapshot of the global clinical trials landscape.
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status.
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company.
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment.
  • The Report provides enrollment trends for the past five years.
  • Report provides latest news for the past three months.

Companies Mentioned

  • Novartis AG
  • Allergan Plc
  • F. Hoffmann-La Roche Ltd
  • Regeneron Pharmaceuticals Inc
  • Bayer AG
  • Alimera Sciences Inc
  • Pfizer Inc
  • Santen Pharmaceutical Co Ltd
  • Valeant Pharmaceuticals International Inc
  • Aerpio Therapeutics Inc

For more information about this clinical trials report visit

View source version on

Business Wire

Last updated on: 31/08/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.